Translating Ideas into Therapies 2021

Dates and times

Start:
June 30^th @ 8:00 am
End:
July 1^st @ 5:00 pm

Event category

External conference, Virtual Conference

Website

Website link

Organiser

ELRIG Committee

Event details

Metrion’s Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Dr Anca Haralambie will be attending “Translating Ideas into Therapies 2021”, Co-hosted by ELRIG and the British Pharmacological Society. The event takes place between Wednesday, 30^th June 2021 and Thursday, 1^st July 2021 and will be held virtually.

The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical stages: 1) Identifying your target. 2) Drugging your target. 3) Gaining clinical insights. These session themes will run sequentially and blend the most exciting science from early career researchers, commercial organisations and key academic, clinical and industry leaders in the field. In addition, an interactive panel discussion will provide the opportunity to share perspectives on some of the most current and innovative routes though which to translate scientific ideas into impactful therapies. Topics in scope for this scientific program will include:

Target Identification & Validation

• Disease-centric biology insights & dealing with increasingly complex target biology
• Leveraging emerging platform technologies
• Deconvoluting target hit lists

Drugging your target

• How new drug formats are changing drug discovery
• New concepts in pharmacology – poly-pharmacology, cellular kinetics etc
• New models of collaborative drug discovery (panel discussion topic)

Clinical insights

• Experimental medicine studies with proprietary and/or essential medicines
• Examples of successful clinical translation of new medicine concepts
• Bringing patient data insights into the discovery pipeline

Through this joint meeting, being organised by ELRIG and the BPS, the aim is to bring together the research community working in the field of new medicine creation with interests in developing their translational research ideas and applying novel technologies and means of collaboration to address critical clinical needs. The organisers of the event encourage scientists from academia, pharma, biotech and CRO’s to come together online to hear talks given by speakers at the cutting edge of their field. 

Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.

If you would like to arrange a meeting with Metrion’s representatives at the event, please contact info@metrionbiosciences.com.